- ►annals.org [PDF] V Miller, A Mocroft, P Reiss, C Katlama, AI … - Annals of internal medicine, 1999 - Am Coll Physicians Veronica Miller, PhD; Amanda Mocroft, PhD; Peter Reiss, MD; Christine Katlama,
MD; Anthony I. Papadopoulos, MD; Terese Katzenstein, MD; Jan van Lunzen, MD;
Francisco Antunes, MD; Andrew N. Phillips, PhD; and Jens D. Lundgren, MD, ... Cited by 126 - Related articles - BL Direct - All 5 versions
O Kirk, JD Lundgren… - Aids, 1999 - journals.lww.com From the Department of Infectious Diseases, Hvidovre Hospital, University of
Copenhagen, Hvidovre, the a Department of Infectious Diseases, Odense University
Hospital, Odense, the b Department of Infectious Diseases, Aalborg ... Cited by 96 - Related articles - BL Direct - All 7 versions
- ►infekt.ch [PDF] H Furrer, M Egger, M Opravil, E Bernasconi, B … - The New England journal of medicine, 1999 - nejm.highwire.org Results Of the 262 patients included in our analysis, 121 (46.2 percent) were
positive for IgG antibodies to Toxoplasma gondii at base line. The median CD4
count at study entry was 325 per cubic millimeter (range, 210 to 806); the ... Cited by 230 - Related articles - BL Direct - All 6 versions
JE Kaplan, DL Hanson, TR Navin, JL Jones - The Journal of infectious diseases, 1998 - UChicago Press Page 1. 1126 Risk Factors for Primary Pneumocystis carinii Pneumonia in Human
Immunodeficiency Virus–Infected Adolescents and Adults ... Cited by 60 - Related articles - BL Direct - All 4 versions
JA Aberg, DM Yajko, MA Jacobson - The Journal of infectious diseases, 1998 - UChicago Press Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ... Cited by 77 - Related articles - BL Direct - All 5 versions
V Soriano, C Dona, R Rodríguez-Rosado, P … - Aids, 2000 - journals.lww.com Background: Immune reconstitution following the introduction of highly active
antiretroviral therapies (HAART) has lead to a remarkable reduction in the
incidence of opportunistic infections (OI) in subjects with advanced HIV ... Cited by 94 - Related articles - All 4 versions
- ►ucl.ac.uk [PDF] B Ledergerber, A Mocroft, P Reiss, H Furrer, … - New England Journal of Medicine, 2001 - content.nejm.org Results Secondary prophylaxis was discontinued at a median CD4 cell count of 350
per cubic millimeter; the median nadir CD4 cell count had been 50 per cubic
millimeter. The median duration of the increase in the CD4 cell count to ... Cited by 152 - Related articles - BL Direct - All 11 versions
J Berenguer, J Cosín, P Miralles, JC López, B … - Aids, 2000 - journals.lww.com Visceral leishmaniasis is an opportunistic infection of advanced HIV disease in
European Mediterranean countries [1,2] . Before or at the time of the first
episode of visceral leishmaniasis, approximately 50% of HIV-infected ... Cited by 33 - Related articles - BL Direct - All 3 versions
SM Whitcup, E Fortin, AS Lindblad, P … - Jama, 1999 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Persons with ... Cited by 157 - Related articles - All 3 versions
D Podzamczer, JM Miro, E Ferrer, JM Gatell, … - European Journal of Clinical Microbiology & Infectious …, 2000 - Springer Abstract An open, randomised, multicentre trial was conducted to evaluate the
effi- cacy of thrice-weekly versus daily therapy with sulfadiazine-pyrimethamine
in the prevention of relapses of toxoplasmic encephalitis in HIV-infected ... Cited by 24 - Related articles - BL Direct - All 3 versions
